Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic's stent for twisted arteries cleared:

This article was originally published in Clinica

Executive Summary

Medtronic has received clearance from the FDA to market a new stent for supporting the heart's more tortuous arteries. The Wiktor Rival system is for treating abrupt or threatened vessel closure in patients with failed interventional therapy or suboptimal percutaneous transluminal coronary angioplasty. The device, which was granted a PMA supplement, has low deployment and post-deployment pressures to protect vessel tissue and eliminate the need for high-pressure balloon catheters, which are time consuming to use and add to cost.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts